Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04213859
Other study ID # 6557-19-SMC
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 24, 2019
Est. completion date September 1, 2023

Study information

Verified date November 2023
Source University of Haifa
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will assess emotional processes and their relation to treatment outcomes during Virtual reality exposure therapy for Flight Phobia. The researchers hypothesize treatment outcomes will be associated with positive changes in emotional constructs


Description:

Emotional constructs and emotion regulation capacities play a central role in the severity of anxiety disorders and are directly related to treatment outcomes in different anxiety disorders. In this study we will examine the relation between positive and negative affect, emotion regulation, emotional instability, emotional differentiation, experiential avoidance and therapy outcomes in participants undergoing Virtual Reality Exposure Therapy for Flight Phobia. We assume that treatment outcomes will be positively related to changes in the regulation, management and experience of emotions.


Recruitment information / eligibility

Status Completed
Enrollment 84
Est. completion date September 1, 2023
Est. primary completion date September 1, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - diagnosis of Flight phobia based on a structured interview - possession of a smartphone with an active data plan Exclusion Criteria: - cardiovascular disease - neurological disorders and history of epilepsy - psychosis - major depression - suicidal behavior - substance abuse.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
VRET - Virtual Reality Exposure Therapy
VRET will include 4 weekly 1-hour sessions over the course of 4 weeks. The treatment protocol is based on the Virtual Reality (VR) treatment manual guidelines (Rothbaum & Hodges, 1997,1999) and includes psychoeducation, anxiety management training, cognitive restructuring and exposure. The first therapy session focuses on creating an individually-tailored conceptualization and treatment plan. Following this process, participant and therapist conduct a short introductory VR flight exposure simulation to familiarize the participant with the VRET apparatus. The VRET apparatus is an advanced, large-scale VR system that allows maximal immersion within the virtual environment. The second, third and fourth sessions include psychoeducation, relaxation training, cognitive restructuring and individually-tailored VR exposures (the therapist can manipulate the turbulence level and other flight-related variables to fit participants' fears and current progress).

Locations

Country Name City State
Israel Sheba Medical Center Ramat Gan

Sponsors (1)

Lead Sponsor Collaborator
Idan Moshe Aderka

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in FAS (Flight Anxiety Situations Questionnaire) scores The Flight Anxiety Situations Questionnaire (Van Grewen, Spinhoven, Van-Dyck, & Dikstra, 1999) is a 32-item, 5-point Likert-scale (1= no anxiety to 5=overwhelming anxiety). The FAS evaluates flight-related anxiety in various situations and includes 3 factors: generalized, anticipatory and in-flight anxiety. Two weeks prior to therapy and one week after last therapy session (therapy includes 4 weekly 1-hour sessions over the course of 4 weeks)
Primary Changes in FAM (Flight Anxiety Modality questionnaire) scores The Flight Anxiety Modality (FAM) questionnaire (Van Grewen et al. 1999) assesses somatic and cognitive aspects of Flight Phobia. It includes 18 items that are rated using a 5-point scale (1=not at all, 5=very intensely). The somatic factor assesses physiological symptoms and the cognitive factor assesses anxiety-provoking cognitions Two weeks prior to therapy and one week after last therapy session (therapy includes 4 weekly 1-hour sessions over the course of 4 weeks).
See also
  Status Clinical Trial Phase
Recruiting NCT06085768 - A Preliminary Study on the Intervention Effect of Virtual Reality Exposure Therapy on Fear of Flying N/A
Completed NCT01623830 - Targeting Reconsolidation to Prevent Return of Fear N/A
Completed NCT02990208 - Diaphragmatic Breathing During Virtual Reality Exposure Therapy for Aviophobia N/A